Watchlist Price Alert

Seres Therapeutics Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

7.12

-0.01 (-0.14%)

At close: Jun 05, 2025, 3:59 PM

7.55

6.01%

After-hours: Jun 05, 2025, 05:59 PM EDT

Seres Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	126.33M	7.13M	144.93M	33.22M	34.51M	28.27M	32.1M	21.77M
Cost of Revenue	n/a	704K	1M	1.73M	90.57M	80.14M	95.95M	89.45M	81.99M
Gross Profit	n/a	125.62M	6.12M	143.19M	-57.35M	-45.64M	-67.69M	-57.35M	-60.22M
Operating Income	-121.31M	-107.98M	-246.49M	-64.49M	-88.13M	-71.88M	-100.28M	-91.39M	-92.84M
Interest Income	3.97M	7.3M	3.06M	2.87M	946K	1.03M	n/a	n/a	2.23M
Pretax Income	136K	-113.72M	-250.16M	-65.58M	-89.13M	-70.28M	-98.94M	-89.38M	-91.58M
Net Income	136K	-113.72M	-253.82M	-61.5M	-86.45M	-64.24M	-98.94M	-89.38M	-91.58M
Selling & General & Admin	53.18M	87.74M	79.69M	69.26M	30.77M	24.75M	32.6M	34.04M	32.62M
Research & Development	64.6M	145.86M	172.92M	141.89M	90.57M	80.14M	95.95M	89.45M	81.99M
Other Expenses	3.53M	n/a	1M	-1.73M	981K	1.07M	170K	425K	n/a
Operating Expenses	121.31M	233.6M	253.62M	209.42M	121.34M	104.89M	128.55M	123.5M	114.61M
Interest Expense	n/a	13.18M	6.02M	2.91M	2.92M	502K	1.17M	1.59M	969K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	234.31M	253.62M	209.42M	121.34M	104.89M	128.55M	123.5M	114.61M
Income Tax Expense	136K	n/a	3.67M	-4.08M	-2.67M	-6.04M	1.34M	-1.59M	2.23M
Shares Outstanding (Basic)	155.4M	128M	108.08M	91.7M	79.79M	56.65M	40.74M	40.45M	39.85M
Shares Outstanding (Diluted)	155.4M	128M	108.08M	91.7M	79.79M	56.65M	40.74M	40.45M	39.85M
EPS (Basic)	0.00	-0.89	-2.35	-0.67	-1.08	-1.13	-2.43	-2.21	-2.3
EPS (Diluted)	0.00	-0.89	-2.35	-0.67	-1.08	-1.13	-2.43	-2.21	-2.3
EBITDA	-121.31M	-94.31M	-237.51M	-56.72M	-77.31M	-59.95M	-91.08M	-82.12M	-88.63M
EBIT	-125.77M	-100.55M	-244.14M	-62.67M	-86.2M	-69.78M	-98.94M	-89.38M	-92.84M
Depreciation & Amortization	n/a	6.24M	11.85M	9.22M	8.89M	9.83M	7.86M	7.26M	4.21M